Literature DB >> 6312232

Minireview: physiological and pharmacological properties of vanadium.

B S Jandhyala, G J Hom.   

Abstract

Vanadium is distributed extensively in nature. It is a trace element and is present in almost all living organisms including man. Even though vanadium was originally recognized for its ability to inhibit membrane Na+-K+-ATPase, various laboratory studies now document that this element has the capacity to affect the activity of various intracellular enzyme systems and may modify their physiological functions. Vanadium may be an essential element for normal development and may play an important role in various homeostatic mechanisms, and thus vanadium deficiency may prove to be an important concern. Abnormalities in biological disposition of vanadium may be involved in the pathogenesis of certain neurological disorders or cardiovascular diseases. While the essentiality of this element for living organisms is yet to be established with certainty, vanadium has become an increasingly important element and is used extensively in various heavy industries such as steel, oil, etc.; thus, the incidence of exposure to toxic levels of vanadium to industrial workers has been an increasing concern for toxicologists. To date, little information is available on the physiological or pharmacological actions of vanadium; hence, it is difficult to reach any definitive conclusion concerning its biological significance, essentiality and its role in pathological states. An attempt has been made in this review to broadly document what is known of various biological actions of vanadium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6312232     DOI: 10.1016/0024-3205(83)90816-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  22 in total

1.  Developmental toxicity evaluation of orthovanadate in the mouse.

Authors:  D Sanchez; A Ortega; J L Domingo; J Corbella
Journal:  Biol Trace Elem Res       Date:  1991-09       Impact factor: 3.738

2.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

3.  Vanadate inhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif.

Authors:  Roberto J Pezza; Marcos A Villarreal; Guillermo G Montich; Carlos E Argaraña
Journal:  Nucleic Acids Res       Date:  2002-11-01       Impact factor: 16.971

4.  Peripheral erythrocyte levels, hemolysis and three vanadium compounds.

Authors:  G R Hogan
Journal:  Experientia       Date:  1990-05-15

5.  Redistribution of subcellular calcium in rat liver on administration of vanadate.

Authors:  S Gullapalli; V Shivaswamy; T Ramasarma; C K Kurup
Journal:  Mol Cell Biochem       Date:  1989-10-31       Impact factor: 3.396

6.  Contractile effects of vanadate on aorta rings from virgin and pregnant rats.

Authors:  J St-Louis; B Sicotte; E Breton; A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 7.  Membrane--vanadium interaction: a toxicokinetic evaluation.

Authors:  R K Upreti
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 8.  Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.

Authors:  J L Domingo; M Gomez; D J Sanchez; J M Llobet; C L Keen
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

9.  Urinary vanadium as a biological indicator of exposure to vanadium.

Authors:  T Kawai; K Seiji; T Wantanabe; H Nakatsuka; M Ikeda
Journal:  Int Arch Occup Environ Health       Date:  1989       Impact factor: 3.015

10.  Extra- and intracellular calcium in vanadate-induced contraction of vascular smooth muscle.

Authors:  S Sunano; T Shimada; K Shimamura; K Moriyama; S Ichida
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.